A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study

Abstract: Patients at risk for progression from myeloid precursor states (idiopathic cytopenia of undetermined significance [ICUS] and clonal cytopenia of undetermined significance [CCUS]) to myelodysplastic syndrome (MDS) are not well defined. Epidemiologic risk factors, clonal changes for MDS deve...

Descripción completa

Detalles Bibliográficos

Autores principales:	Amy E. DeZern, Nancy Gillis, Michael Otterstatter, Gregory Abel, Eric Padron, H. Joachim Deeg, Tareq Al Baghdadi, Jane Liu, Zhuoer Xie, Ling Zhang, Lynn Moscinski, Steven Kroft, Alexandra Harrington, James Foran, Rami Komrokji, Daniel Starczynowski, Steven Gore, Wael Saber, Rafael Bejar, R. C. Lindsley, Seth Sherman, Cecilia Lee, Nancy DiFronzo, Matthew Walter, Mikkael A. Sekeres
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2026-04-01
Colección:	Blood Advances
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2473952926001345
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!